Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 31 Mar 2016 for ROCK CREEK PHARMACEUTICALS, INC., €88k.
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Robert Scannell: trading record in brief
Our data holds just one disclosure by Robert Scannell, dated 31 March 2016, reporting an open-market purchase worth €88k in Rock Creek Pharmaceuticals, Inc. Further filings will be added here. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Robert Scannell
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
- 285,714 shares@ US$0.35Common StockSEC:0001140361-16-059675:0Canonical exit: 28 Jun 2016 (T+90)
1 of 1 declaration